August 11, 2020 02:42 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
After Vivo exit, Ramdev's Patanjali considering to bid for IPL title sponsorship | Assam: Massive fire in Jorhat kills two, several injured | Former President Pranab Mukherjee tests positive for Covid-19 | Kashmir: Two militant OGWs arrested, arms, ammunition recovered in Sopore | Kashmir: Injured BJP worker dies, large number of people attend last rites
India aims to launch indigenous Covid-19 vaccine by Aug 15 with ICMR partnering with Bharat Biotech

India aims to launch indigenous Covid-19 vaccine by Aug 15 with ICMR partnering with Bharat Biotech

India Blooms News Service | @indiablooms | 03 Jul 2020, 08:39 am

New Delhi/IBNS: The Indian Council of Medical Research (ICMR) has partnered with Bharat Biotech International Limited (BBIL) to fast-track the clinical trials of Covid-19 vaccine, giving India a chance to come up with its indigenous cure for the deadly virus, media reports said.

ICMR director general Balram Bhargava said in a statement as quoted by Zee News, "It is envisaged to launch the vaccine for public health use latest by 15th August 2020 after completion of all clinical trials. BBIL is working expeditiously to meet the target, however, final outcome will depend on the cooperation of all clinical trial sites involved in this project."

The statement further read, "This is the first indigenous vaccine being developed by India and is one of the top priority projects which is being monitored at the topmost level of the Government.

"The vaccine is derived from a strain of SARS-CoV-2 isolated by ICMR-National Institute of Virology, Pune. ICMR and BBIL are jointly working for the preclinical as well as clinical development of this vaccine."

Bharat Biotech's vaccine candidate COVAXIN had received the nod of the Drug Controller General of India (DCGI) on Jun 30.

The Drug Controller General of India - CDSCO, Ministry of Health & Family Welfare, has already granted permission to start phase I and phase II of human trials after the company showed the preclinical studies, demonstrating safety and immune response.

Related Images
Kolkata witnesses 'supermoon' 01 Jan 1970, 05:30 am
Related Videos
Covid-19 press briefing by WHO 01 Jan 1970, 05:30 am
Covid-19 press briefing in India 01 Jan 1970, 05:30 am